Oral evidence transcript
| Published on: | Thursday 14 December 2017 |
|---|---|
| Date: | Tuesday 12 December 2017 |
| Meeting on: | Tuesday 12 December 2017 |
| Part of event segment: | Untitled |
| Document ID: | 156466 |
| Citations: |
|
Committees
Work packages
-
Brexit – medicines, medical devices and substances of human origin inquiry
Wednesday 20 September 2017 - Thursday 31 May 2018
Witnesses
-
Dr Jayne Spink, Chief Executive, Genetic Alliance UK, Dr Beth Thompson, Head of UK and EU Policy, The Wellcome Trust, Aisling Burnand MBE, Chief Executive, Association of Medical Research CharitiesSteve Bates, Chief Executive, BioIndustry Association, Leslie Galloway, Chairman, Ethical Medicines Industry Group, Suzanne Halliday, Head of Medical Devices, British Standards Institution, Doris-Ann Williams MBE, Chief Executive, British In-vitro Diagnostics Association